Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.
Jiang Y, Jiang YY, Xie JJ, Mayakonda A, Hazawa M, Chen L, Xiao JF, Li CQ, Huang ML, Ding LW, Sun QY, Xu L, Kanojia D, Jeitany M, Deng JW, Liao LD, Soukiasian HJ, Berman BP, Hao JJ, Xu LY, Li EM, Wang MR, Bi XG, Lin DC, Koeffler HP.
Jiang Y, et al. Among authors: lin dc.
Nat Commun. 2018 Sep 6;9(1):3619. doi: 10.1038/s41467-018-06081-9.
Nat Commun. 2018.
PMID: 30190462
Free PMC article.